215 related articles for article (PubMed ID: 15766566)
1. PU.1 silencing leads to terminal differentiation of erythroleukemia cells.
Atar O; Levi BZ
Biochem Biophys Res Commun; 2005 Apr; 329(4):1288-92. PubMed ID: 15766566
[TBL] [Abstract][Full Text] [Related]
2. Deregulated expression of the PU.1 transcription factor blocks murine erythroleukemia cell terminal differentiation.
Rao G; Rekhtman N; Cheng G; Krasikov T; Skoultchi AI
Oncogene; 1997 Jan; 14(1):123-31. PubMed ID: 9010239
[TBL] [Abstract][Full Text] [Related]
3. The role of Ets family transcription factor PU.1 in hematopoietic cell differentiation, proliferation and apoptosis.
Oikawa T; Yamada T; Kihara-Negishi F; Yamamoto H; Kondoh N; Hitomi Y; Hashimoto Y
Cell Death Differ; 1999 Jul; 6(7):599-608. PubMed ID: 10453070
[TBL] [Abstract][Full Text] [Related]
4. PU.1: a crucial and versatile player in hematopoiesis and leukemia.
Kastner P; Chan S
Int J Biochem Cell Biol; 2008; 40(1):22-7. PubMed ID: 17374502
[TBL] [Abstract][Full Text] [Related]
5. Prevention of PU.1-induced growth inhibition and apoptosis but not differentiation block in murine erythroleukemia cells by overexpression of CBP.
Manabe N; Yamamoto H; Yamada T; Kihara-Negishi F; Hashimoto Y; Mochizuki M; Oikawa T
Int J Oncol; 2003 Jun; 22(6):1345-50. PubMed ID: 12739003
[TBL] [Abstract][Full Text] [Related]
6. Effects of PU.1-induced mouse calcium-calmodulin-dependent kinase I-like kinase (CKLiK) on apoptosis of murine erythroleukemia cells.
Yamada T; Suzuki M; Satoh H; Kihara-Negishi F; Nakano H; Oikawa T
Exp Cell Res; 2004 Mar; 294(1):39-50. PubMed ID: 14980499
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of Friend cells proliferation by spi-1 antisense oligodeoxynucleotides.
Delgado MD; Hallier M; Meneceur P; Tavitian A; Moreau-Gachelin F
Oncogene; 1994 Jun; 9(6):1723-7. PubMed ID: 8183568
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of the Spi-1/PU.1 oncogene induces the expression of TRIM10/HERF1, a key factor required for terminal erythroid cell differentiation and survival.
Blaybel R; Théoleyre O; Douablin A; Baklouti F
Cell Res; 2008 Aug; 18(8):834-45. PubMed ID: 18560381
[TBL] [Abstract][Full Text] [Related]
9. PU.1 is dispensable to block erythroid differentiation in Friend erythroleukemia cells.
Fernández-Nestosa MJ; Hernández P; Schvartzman JB; Krimer DB
Leuk Res; 2008 Jan; 32(1):121-30. PubMed ID: 17586044
[TBL] [Abstract][Full Text] [Related]
10. Interaction between the homeodomain protein HOXC13 and ETS family transcription factor PU.1 and its implication in the differentiation of murine erythroleukemia cells.
Yamada T; Shimizu T; Suzuki M; Kihara-Negishi F; Nanashima N; Sakurai T; Fan Y; Akita M; Oikawa T; Tsuchida S
Exp Cell Res; 2008 Feb; 314(4):847-58. PubMed ID: 18076876
[TBL] [Abstract][Full Text] [Related]
11. Kit-activating mutations cooperate with Spi-1/PU.1 overexpression to promote tumorigenic progression during erythroleukemia in mice.
Kosmider O; Denis N; Lacout C; Vainchenker W; Dubreuil P; Moreau-Gachelin F
Cancer Cell; 2005 Dec; 8(6):467-78. PubMed ID: 16338660
[TBL] [Abstract][Full Text] [Related]
12. Subtle distinct regulations of late erythroid molecular events by PI3K/AKT-mediated activation of Spi-1/PU.1 oncogene autoregulation loop.
Breig O; Théoleyre O; Douablin A; Baklouti F
Oncogene; 2010 May; 29(19):2807-16. PubMed ID: 20190819
[TBL] [Abstract][Full Text] [Related]
13. PU.1 immortalizes hematopoietic progenitors in a GM-CSF-dependent manner.
Houston IB; Huang KJ; Jennings SR; DeKoter RP
Exp Hematol; 2007 Mar; 35(3):374-384. PubMed ID: 17309818
[TBL] [Abstract][Full Text] [Related]
14. Spi-1/PU.1 but not Fli-1 inhibits erythroid-specific alternative splicing of 4.1R pre-mRNA in murine erythroleukemia cells.
Théoleyre O; Deguillien M; Morinière M; Starck J; Moreau-Gachelin F; Morlé F; Baklouti F
Oncogene; 2004 Jan; 23(4):920-7. PubMed ID: 14647452
[TBL] [Abstract][Full Text] [Related]
15. GOOSECOID inhibits erythrocyte differentiation by competing with Rb for PU.1 binding in murine cells.
Konishi Y; Tominaga M; Watanabe Y; Imamura F; Goldfarb A; Maki R; Blum M; De Robertis EM; Tominaga A
Oncogene; 1999 Nov; 18(48):6795-805. PubMed ID: 10597288
[TBL] [Abstract][Full Text] [Related]
16. Oncogene cooperativity in Friend erythroleukemia: erythropoietin receptor activation by the env gene of SFFV leads to transcriptional upregulation of PU.1, independent of SFFV proviral insertion.
Afrikanova I; Yeh E; Bartos D; Watowich SS; Longmore GD
Oncogene; 2002 Feb; 21(8):1272-84. PubMed ID: 11850847
[TBL] [Abstract][Full Text] [Related]
17. Lymphoid cell growth and transformation are suppressed by a key regulatory element of the gene encoding PU.1.
Rosenbauer F; Owens BM; Yu L; Tumang JR; Steidl U; Kutok JL; Clayton LK; Wagner K; Scheller M; Iwasaki H; Liu C; Hackanson B; Akashi K; Leutz A; Rothstein TL; Plass C; Tenen DG
Nat Genet; 2006 Jan; 38(1):27-37. PubMed ID: 16311598
[TBL] [Abstract][Full Text] [Related]
18. Reprogramming leukemia cells to terminal differentiation and growth arrest by RNA interference of PU.1.
Papetti M; Skoultchi AI
Mol Cancer Res; 2007 Oct; 5(10):1053-62. PubMed ID: 17951405
[TBL] [Abstract][Full Text] [Related]
19. A Myb dependent pathway maintains Friend murine erythroleukemia cells in an immature and proliferating state.
Chen J; Kremer CS; Bender TP
Oncogene; 2002 Mar; 21(12):1859-69. PubMed ID: 11896618
[TBL] [Abstract][Full Text] [Related]
20. Involvement of PU.1 in the transcriptional regulation of TNF-alpha.
Fukai T; Nishiyama C; Kanada S; Nakano N; Hara M; Tokura T; Ikeda S; Ogawa H; Okumura K
Biochem Biophys Res Commun; 2009 Oct; 388(1):102-6. PubMed ID: 19646961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]